These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


450 related items for PubMed ID: 26423551

  • 1. Effect of baseline CD4 cell count at linkage to HIV care and at initiation of antiretroviral therapy on mortality in HIV-positive adult patients in Rwanda: a nationwide cohort study.
    Nsanzimana S, Remera E, Kanters S, Forrest JI, Ford N, Condo J, Binagwaho A, Bucher H, Thorlund K, Vitoria M, Mills EJ.
    Lancet HIV; 2015 Sep; 2(9):e376-84. PubMed ID: 26423551
    [Abstract] [Full Text] [Related]

  • 2. Effect of immediate initiation of antiretroviral therapy on risk of severe bacterial infections in HIV-positive people with CD4 cell counts of more than 500 cells per μL: secondary outcome results from a randomised controlled trial.
    O'Connor J, Vjecha MJ, Phillips AN, Angus B, Cooper D, Grinsztejn B, Lopardo G, Das S, Wood R, Wilkin A, Klinker H, Kantipong P, Klingman KL, Jilich D, Herieka E, Denning E, Abubakar I, Gordin F, Lundgren JD, INSIGHT START study group.
    Lancet HIV; 2017 Mar; 4(3):e105-e112. PubMed ID: 28063815
    [Abstract] [Full Text] [Related]

  • 3. HIV care continuum in Rwanda: a cross-sectional analysis of the national programme.
    Nsanzimana S, Kanters S, Remera E, Forrest JI, Binagwaho A, Condo J, Mills EJ.
    Lancet HIV; 2015 May; 2(5):e208-15. PubMed ID: 26423003
    [Abstract] [Full Text] [Related]

  • 4. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.
    Mutimura E, Addison D, Anastos K, Hoover D, Dusingize JC, Karenzie B, Izimukwiye I, Mutesa L, Nsanzimana S, Nash D, IeDEA Central Africa Collaboration.
    AIDS; 2015 Jan 02; 29(1):67-76. PubMed ID: 25562492
    [Abstract] [Full Text] [Related]

  • 5. Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study.
    Lodi S, Phillips A, Logan R, Olson A, Costagliola D, Abgrall S, van Sighem A, Reiss P, Miró JM, Ferrer E, Justice A, Gandhi N, Bucher HC, Furrer H, Moreno S, Monge S, Touloumi G, Pantazis N, Sterne J, Young JG, Meyer L, Seng R, Dabis F, Vandehende MA, Pérez-Hoyos S, Jarrín I, Jose S, Sabin C, Hernán MA, HIV-CAUSAL Collaboration.
    Lancet HIV; 2015 Aug 02; 2(8):e335-43. PubMed ID: 26423376
    [Abstract] [Full Text] [Related]

  • 6. Determinants of mortality and loss to follow-up among adults enrolled in HIV care services in Rwanda.
    Mugisha V, Teasdale CA, Wang C, Lahuerta M, Nuwagaba-Biribonwoha H, Tayebwa E, Ingabire E, Ingabire P, Sahabo R, Twyman P, Abrams EJ, Identifying Optimal Models for HIV Care in Rwanda Collaboration.
    PLoS One; 2014 Aug 02; 9(1):e85774. PubMed ID: 24454931
    [Abstract] [Full Text] [Related]

  • 7. Immediate Antiretroviral Therapy Decreases Mortality Among Patients With High CD4 Counts in China: A Nationwide, Retrospective Cohort Study.
    Zhao Y, Wu Z, McGoogan JM, Shi CX, Li A, Dou Z, Ma Y, Qin Q, Brookmeyer R, Detels R, Montaner JSG.
    Clin Infect Dis; 2018 Feb 10; 66(5):727-734. PubMed ID: 29069362
    [Abstract] [Full Text] [Related]

  • 8. Trends of CD4 cell count levels at the initiation of antiretroviral therapy over time and factors associated with late initiation of antiretroviral therapy among Asian HIV-positive patients.
    Kiertiburanakul S, Boettiger D, Lee MP, Omar SF, Tanuma J, Ng OT, Durier N, Phanuphak P, Ditangco R, Chaiwarith R, Kantipong P, Lee CK, Mustafa M, Saphonn V, Ratanasuwan W, Merati TP, Kumarasamy N, Wong WW, Zhang F, Pham TT, Pujari S, Choi JY, Yunihastuti E, Sungkanuparph S, TREAT Asia HIV Observational Databases (TAHOD), TREAT Asia Studies to Evaluate Resistance (TASER).
    J Int AIDS Soc; 2014 Feb 10; 17(1):18804. PubMed ID: 24598459
    [Abstract] [Full Text] [Related]

  • 9. Determinants of time to antiretroviral treatment initiation and subsequent mortality on treatment in a cohort in rural northern Malawi.
    Brown JP, Ngwira B, Tafatatha T, Crampin AC, French N, Koole O.
    AIDS Res Ther; 2016 Feb 10; 13():24. PubMed ID: 27398087
    [Abstract] [Full Text] [Related]

  • 10. Life expectancy among HIV-positive patients in Rwanda: a retrospective observational cohort study.
    Nsanzimana S, Remera E, Kanters S, Chan K, Forrest JI, Ford N, Condo J, Binagwaho A, Mills EJ.
    Lancet Glob Health; 2015 Mar 10; 3(3):e169-77. PubMed ID: 25701995
    [Abstract] [Full Text] [Related]

  • 11. Age in antiretroviral therapy programmes in South Africa: a retrospective, multicentre, observational cohort study.
    Cornell M, Johnson LF, Schomaker M, Tanser F, Maskew M, Wood R, Prozesky H, Giddy J, Stinson K, Egger M, Boulle A, Myer L, International Epidemiologic Databases to Evaluate AIDS-Southern Africa Collaboration.
    Lancet HIV; 2015 Sep 10; 2(9):e368-75. PubMed ID: 26423550
    [Abstract] [Full Text] [Related]

  • 12. Effect of point-of-care CD4 cell count results on linkage to care and antiretroviral initiation during a home-based HIV testing campaign: a non-blinded, cluster-randomised trial.
    Desai MA, Okal DO, Rose CE, Ndivo R, Oyaro B, Otieno FO, Williams T, Chen RT, Zeh C, Samandari T.
    Lancet HIV; 2017 Sep 10; 4(9):e393-e401. PubMed ID: 28579225
    [Abstract] [Full Text] [Related]

  • 13. Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strata.
    Palella FJ, Deloria-Knoll M, Chmiel JS, Moorman AC, Wood KC, Greenberg AE, Holmberg SD, HIV Outpatient Study Investigators.
    Ann Intern Med; 2003 Apr 15; 138(8):620-6. PubMed ID: 12693883
    [Abstract] [Full Text] [Related]

  • 14. Initiation of antiretroviral therapy in HIV-infected tuberculosis patients in rural Kenya: an observational study.
    Stockdale AJ, Nkuranga J, Török ME, Faragher B, Lalloo DG.
    Trop Med Int Health; 2013 Jul 15; 18(7):907-14. PubMed ID: 23590229
    [Abstract] [Full Text] [Related]

  • 15. Factors associated with antiretroviral treatment initiation amongst HIV-positive individuals linked to care within a universal test and treat programme: early findings of the ANRS 12249 TasP trial in rural South Africa.
    Boyer S, Iwuji C, Gosset A, Protopopescu C, Okesola N, Plazy M, Spire B, Orne-Gliemann J, McGrath N, Pillay D, Dabis F, Larmarange J, ANRS 12249 TasP study group.
    AIDS Care; 2016 Jul 15; 28 Suppl 3(Suppl 3):39-51. PubMed ID: 27421051
    [Abstract] [Full Text] [Related]

  • 16. Demographic and clinical factors correlated with clinical outcomes among people with HIV treated by antiretroviral therapy: a retrospective cohort study.
    Li Y, Liu H, Zhang S, Zhang Y, Wang H, Zhang H, Li X.
    BMC Infect Dis; 2024 May 22; 24(1):514. PubMed ID: 38778273
    [Abstract] [Full Text] [Related]

  • 17. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.
    When To Start Consortium, Sterne JA, May M, Costagliola D, de Wolf F, Phillips AN, Harris R, Funk MJ, Geskus RB, Gill J, Dabis F, Miró JM, Justice AC, Ledergerber B, Fätkenheuer G, Hogg RS, Monforte AD, Saag M, Smith C, Staszewski S, Egger M, Cole SR.
    Lancet; 2009 Apr 18; 373(9672):1352-63. PubMed ID: 19361855
    [Abstract] [Full Text] [Related]

  • 18. Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective, international, randomised, placebo-controlled trial.
    Mfinanga SG, Kirenga BJ, Chanda DM, Mutayoba B, Mthiyane T, Yimer G, Ezechi O, Connolly C, Kapotwe V, Muwonge C, Massaga J, Sinkala E, Kohi W, Lyantumba L, Nyakoojo G, Luwaga H, Doulla B, Mzyece J, Kapata N, Vahedi M, Mwaba P, Egwaga S, Adatu F, Pym A, Joloba M, Rustomjee R, Zumla A, Onyebujoh P.
    Lancet Infect Dis; 2014 Jul 18; 14(7):563-71. PubMed ID: 24810491
    [Abstract] [Full Text] [Related]

  • 19. Task shifting of antiretroviral treatment from doctors to primary-care nurses in South Africa (STRETCH): a pragmatic, parallel, cluster-randomised trial.
    Fairall L, Bachmann MO, Lombard C, Timmerman V, Uebel K, Zwarenstein M, Boulle A, Georgeu D, Colvin CJ, Lewin S, Faris G, Cornick R, Draper B, Tshabalala M, Kotze E, van Vuuren C, Steyn D, Chapman R, Bateman E.
    Lancet; 2012 Sep 08; 380(9845):889-98. PubMed ID: 22901955
    [Abstract] [Full Text] [Related]

  • 20. Comparing Outcomes of HIV-Infected Chinese Adults on Antiretroviral Therapy by CD4 Count at Treatment Initiation: A Nationwide Retrospective Observational Cohort Study, 2012-2014.
    Hu R, Zhang F, Wang V, Dou Z, Shepard C, Zhao D, Liu X, Mu W, Wu Y, Zhao H, Li H.
    AIDS Patient Care STDS; 2017 Oct 08; 31(10):413-420. PubMed ID: 28981337
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.